Search This Blog

Thursday, November 20, 2025

AstraZeneca's Alexion gets FDA approval for Koselugo

  Alexion, part of AstraZeneca (AZN), said that the FDA has approved Koselugo for the treatment of adults with neurofibromatosis.

https://seekingalpha.com/news/4524489-astrazenecas-alexion-gets-fda-approval-for-koselugo

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.